Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 10, 2001, Pages 1673-1679

  Netzer, P ^a,b,c   Domek, M ^a,b   Pai, R ^a,b   Halter, F ^a,b   Tarnawski, A ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CATION; FIBROBLAST GROWTH FACTOR; LIPOSOME; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CULTURE; CELL GROWTH; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; CATIONS; CELL DIVISION; CELL SURVIVAL; COLONIC NEOPLASMS; FIBROBLAST GROWTH FACTORS; HT29 CELLS; HUMANS; LIPOSOMES; OLIGONUCLEOTIDES, ANTISENSE; PILOT PROJECTS; RNA, MESSENGER;

EID: 0034789197     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01084.x     Document Type: Article

References (50)

1. Cancer statistics, 2000
2. Malignant neoplasms of the large intestine
3. Prevention of colorectal cancer by colonoscopic polypectomy
4. Colorectal cancer screening: Clinical guidelines and rationale (American Gastroenterological Association)
5. Significance of histologic criteria for the management of patients with malignant colorectal polyps and polypectomy
6. Risk factor assessment of endoscopically removed malignant colorectal polyps
7. Antisense inhibition of oncogene expression
8. Gene inhibition using antisense oligodeoxynucleotides
9. Moleculare Medicine: Antisense-oligonucleotide therapy
10. Review article: Gene therapy in gastroenterology and hepatology
11. Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468
12. Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines
13. Amphiregulin antisense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line
14. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor
15. Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line
16. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
17. In vivo electrophoretic transfer of bcl-2 antisense oligonucleotide inhibits the development of hepatocellular carcinoma in rats
18. Fibroblast growth factor-2
19. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines
20. Basic fibroblast growth factor increases the multiplication and migration of serum-free derivative of CaCo-2 but does not affect differentiation
21. Heparin oligosaccharides: Inhibitors of the biological activity of bFGF on Caco-2 cells
22. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo
23. Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin
24. Progessive upregulation of metastasis-related genes in human colon cancer cells implanted into the cecum of nude mice
25. Invasion of human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor
26. Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium
27. Basic fibroblast growth factor increases the number of excitatory neurons containing glutamate in the cerebral cortex
28. Block of AIDS-Kaposi Sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor
29. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides
30. Human basic fibroblast growth factor: Nucleotide sequence and genomic organization
31. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes
32. Cationic lipids enhance cellular uptake and activitiy of phosphorothioate antisense oligonucleotides
33. Characterization of a novel member of the FGF family, XFGF-20, in Xenopus laevis
34. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): An insight into an intracrine mechanism
35. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: Interaction with indomethacin
36. Fibroblast growth factors modulate intestinal epithelial cell growth and migration
37. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer
38. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
39. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer
40. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells
41. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
42. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
43. Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects
44. Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis
45. Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma
46. Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide
47. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA
48. Antisense oligonucleotides: Is the glass half full or half empty?
49. Not nonsense but antisense - Applications of antisense oligonucleotides in different fields of medicine
50. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides